Trials / Completed
CompletedNCT03946813
The Efficacy of Platelets Rich Plasma for Ovarian Rejuvenation
The Efficacy of Platelets Rich Plasma (PRP) for Ovarian Rejuvenation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Al-Kindy College of Medicine · Academic / Other
- Sex
- Female
- Age
- 20 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
In recent years, an increased approach has appeared in the use of autologous blood products to assist tissue and organ healing. Application of platelet rich plasma (PRP) has emerged as a potential solution for infertile women with poor ovarian reserve in reproductive specialty.
Detailed description
Quantitative and qualitative functional improvement of ovarian function has been reported in several studies after using autologous PRP in a reproductive field. Ovarian rejuvenation, stimulating the ovaries to produce new eggs after injecting PRP, can offer hope for renewed fertility to women with poor reserve volume, advanced maternal age, or either naturally occurring or premature menopause. But, these encouraging results should be supported by several new studies. This study aimed to estimate the efficacy of trans-vaginal ovarian injection with PRP in rejuvenates ovaries in woman with poor ovarian reserve, and to assess any association of some women variables (age, menstrual status, parity, BMI) as predicting factors in success of ovarian injection with PRP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Autologous PRP preparation | For each patient, autologous PRP preparation havs to be injected to both ovaries and ultrasound (US) guide |
Timeline
- Start date
- 2018-08-20
- Primary completion
- 2019-05-31
- Completion
- 2019-05-31
- First posted
- 2019-05-13
- Last updated
- 2023-05-06
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT03946813. Inclusion in this directory is not an endorsement.